FAKTOR-ZERTIFIKAT - BIOGEN IDEC | Market Closed - Börse Stuttgart 01:19:01 25/05/2024 am IST | ||
| 3.74 EUR | -31.88% |
|
| Current month | -21.26% | ||
| 1 month | +27.65% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 3.74 | -31.88% |
| 23/24/23 | 5.49 | +0.37% |
| 22/24/22 | 5.47 | -24.13% |
| 21/24/21 | 7.21 | +1.26% |
| 20/24/20 | 7.12 | +3.04% |
Delayed Quote Börse Stuttgart
Last update May 25, 2024 at 01:19 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | J.P. Morgan |
| WKN | JK4CZ1 |
| ISIN | DE000JK4CZ16 |
| Date issued | 22/03/2024 |
| Strike | 193.9 $ |
| Maturity | Unlimited |
| Parity | 6.19 : 1 |
| Emission price | 10.18 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.02 € |
|---|---|
| Lowest since issue | 1.87 € |
| Spread | 0.3 € |
| Spread % | 7.30% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
217.8
USD
Average target price
286.1
USD
Spread / Average Target
+31.33%
- Stock Market
- Certificates
- Certificat
